Rxivist logo

Why cancer cells have a more hyperpolarised mitochondrial membrane potential and emergent prospects for therapy

By Michael D Forrest

Posted 21 Aug 2015
bioRxiv DOI: 10.1101/025197

Cancer cells have a more hyperpolarised mitochondrial membrane potential (Ψ) than normal cells. Ψ = ~-220 mV in cancer cells as compared to ~-140 mV in normal cells. Until now it has not been known why. This paper explains this disparity, in a mathematical framework, and identifies molecular targets and operations unique to cancer cells. These are thence prospective cancer drug targets. BMS-199264 is proposed as an anti-cancer drug. It inhibits the reverse, proton-pumping mode of ATP synthase, which this paper identifies as crucial to cancer cells but not to healthy, normal adult cells. In the cancer cell model, the adenine nucleotide exchanger (ANT) is inversely orientated in the mitochondrial inner membrane as compared to normal cells. This predicts it to have a different drug interaction profile, which can be leveraged for cancer therapy. Uncouplers, which dissipate the proton motive force, are proposed as anti-cancer medicines e.g. 2,4-dinitrophenol.

Download data

  • Downloaded 9,608 times
  • Download rankings, all-time:
    • Site-wide: 268 out of 89,651
    • In cancer biology: 5 out of 3,161
  • Year to date:
    • Site-wide: 2,262 out of 89,651
  • Since beginning of last month:
    • Site-wide: 3,501 out of 89,651

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide


Sign up for the Rxivist weekly newsletter! (Click here for more details.)